TY - JOUR
T1 - Predicting waist circumference from body mass index
AU - Bozeman, Samuel R.
AU - Hoaglin, David C.
AU - Burton, Tanya M.
AU - Pashos, Chris L.
AU - Ben-Joseph, Rami H.
AU - Hollenbeak, Christopher S.
N1 - Funding Information:
The majority of the work overall, including this manuscript, has not been performed with sponsorship funding. Initial aspects of this work were sponsored by Sanofi-Aventis, which funded Abt Bio-Pharma Solutions, a subsidiary of Abt Associates, Inc., to lead this study. In that initial stage, SRB performed the research as an employee of Abt Associates; DCH, TMB and CLP performed this study as employees of Abt Bio-Pharma Solutions, now part of United BioSource Corporation; RHBJ contributed as an employee of Sanofi-Aventis; and CSH contributed as an employee of Pennsylvania State University.
PY - 2012
Y1 - 2012
N2 - Background: Being overweight or obese increases risk for cardiometabolic disorders. Although both body mass index (BMI) and waist circumference (WC) measure the level of overweight and obesity, WC may be more important because of its closer relationship to total body fat. Because WC is typically not assessed in clinical practice, this study sought to develop and verify a model to predict WC from BMI and demographic data, and to use the predicted WC to assess cardiometabolic risk. Methods: Data were obtained from the Third National Health and Nutrition Examination Survey (NHANES) and the Atherosclerosis Risk in Communities Study (ARIC). We developed linear regression models for men and women using NHANES data, fitting waist circumference as a function of BMI. For validation, those regressions were applied to ARIC data, assigning a predicted WC to each individual. We used the predicted WC to assess abdominal obesity and cardiometabolic risk. Results: The model correctly classified 88.4% of NHANES subjects with respect to abdominal obesity. Median differences between actual and predicted WC were - 0.07 cm for men and 0.11 cm for women. In ARIC, the model closely estimated the observed WC (median difference: - 0.34 cm for men, +3.94 cm for women), correctly classifying 86.1% of ARIC subjects with respect to abdominal obesity and 91.5% to 99.5% as to cardiometabolic risk. The model is generalizable to Caucasian and African-American adult populations because it was constructed from data on a large, population-based sample of men and women in the United States, and then validated in a population with a larger representation of African-Americans. Conclusions: The model accurately estimates WC and identifies cardiometabolic risk. It should be useful for health care practitioners and public health officials who wish to identify individuals and populations at risk for cardiometabolic disease when WC data are unavailable.
AB - Background: Being overweight or obese increases risk for cardiometabolic disorders. Although both body mass index (BMI) and waist circumference (WC) measure the level of overweight and obesity, WC may be more important because of its closer relationship to total body fat. Because WC is typically not assessed in clinical practice, this study sought to develop and verify a model to predict WC from BMI and demographic data, and to use the predicted WC to assess cardiometabolic risk. Methods: Data were obtained from the Third National Health and Nutrition Examination Survey (NHANES) and the Atherosclerosis Risk in Communities Study (ARIC). We developed linear regression models for men and women using NHANES data, fitting waist circumference as a function of BMI. For validation, those regressions were applied to ARIC data, assigning a predicted WC to each individual. We used the predicted WC to assess abdominal obesity and cardiometabolic risk. Results: The model correctly classified 88.4% of NHANES subjects with respect to abdominal obesity. Median differences between actual and predicted WC were - 0.07 cm for men and 0.11 cm for women. In ARIC, the model closely estimated the observed WC (median difference: - 0.34 cm for men, +3.94 cm for women), correctly classifying 86.1% of ARIC subjects with respect to abdominal obesity and 91.5% to 99.5% as to cardiometabolic risk. The model is generalizable to Caucasian and African-American adult populations because it was constructed from data on a large, population-based sample of men and women in the United States, and then validated in a population with a larger representation of African-Americans. Conclusions: The model accurately estimates WC and identifies cardiometabolic risk. It should be useful for health care practitioners and public health officials who wish to identify individuals and populations at risk for cardiometabolic disease when WC data are unavailable.
UR - http://www.scopus.com/inward/record.url?scp=84864496932&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864496932&partnerID=8YFLogxK
U2 - 10.1186/1471-2288-12-115
DO - 10.1186/1471-2288-12-115
M3 - Article
C2 - 22862851
AN - SCOPUS:84864496932
SN - 1471-2288
VL - 12
JO - BMC Medical Research Methodology
JF - BMC Medical Research Methodology
M1 - 115
ER -